Diabetes Care, Vol 21, Issue 4 487-493, Copyright © 1998 by American Diabetes Association

ARTICLES

Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment

AC Desfaits, O Serri and G Renier
Metabolic Unit, CHUM Research Center, Montreal, Quebec, Canada.

OBJECTIVE: To evaluate the effect of gliclazide administration to NIDDM patients on 1) monocyte adhesion to cultured endothelial cells, 2) plasma cytokine and lipid peroxide levels, and 3) monocyte cytokine production. RESEARCH DESIGN AND METHODS: Poorly controlled glyburide-treated diabetic patients (n = 8) and healthy control subjects (n = 8) were recruited. At the beginning of the study, glyburide was replaced by an equivalent hypoglycemic dose of gliclazide. Serum and monocytes were isolated from blood obtained from control and diabetic subjects before and after 3 months of treatment with gliclazide. RESULTS: Plasma lipid peroxide levels and monocyte adhesion to endothelial cells are enhanced in NIDDM patients, and gliclazide administration totally reverses these abnormalities. Before gliclazide treatment, serum levels of cytokines did not differ in the control and the diabetic groups, with the exception of an enhancement of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL)-6 in NIDDM subjects. Basal and lipopolysaccharide (LPS)-stimulated monocyte production of interleukin-1 beta, IL-6, and IL-8 did not differ between the two groups. Furthermore, basal monocyte production of TNF-alpha was similar in the control and the diabetic groups, whereas a marked increase in the LPS-stimulated monocyte production of TNF-alpha was observed in the NIDDM group. Gliclazide treatment lowered LPS-stimulated TNF-alpha production by diabetic monocytes to levels similar to those observed in control subjects. CONCLUSIONS: Gliclazide administration to NIDDM patients inhibits the increased adhesiveness of diabetic monocytes to endothelial cells and reduces the production of TNF-alpha by these cells. These results suggest that treatment of NIDDM subjects with gliclazide may be beneficial in the prevention of atherosclerosis associated with NIDDM.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. A. Mooney COUNTERPOINT: INTERLEUKIN-6 DOES NOT HAVE A BENEFICIAL ROLE IN INSULIN SENSITIVITY AND GLUCOSE HOMEOSTASIS J Appl Physiol, February 1, 2007; 102(2): 816 - 818. [Full Text] [PDF]

				B. K. Pedersen, M. A. Febbraio, and R. A. Mooney Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis J Appl Physiol, February 1, 2007; 102(2): 814 - 816. [Full Text] [PDF]

				W. Cao, Q. F. Collins, T. C. Becker, J. Robidoux, E. G. Lupo Jr., Y. Xiong, K. W. Daniel, L. Floering, and S. Collins p38 Mitogen-activated Protein Kinase Plays a Stimulatory Role in Hepatic Gluconeogenesis J. Biol. Chem., December 30, 2005; 280(52): 42731 - 42737. [Abstract] [Full Text] [PDF]

				M. T. Coughlan, M. Permezel, H. M. Georgiou, and G. E. Rice Repression of Oxidant-Induced Nuclear Factor-{kappa}B Activity Mediates Placental Cytokine Responses in Gestational Diabetes J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3585 - 3594. [Abstract] [Full Text] [PDF]

				A. G. Pittas, N. A. Joseph, and A. S. Greenberg Adipocytokines and Insulin Resistance J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 447 - 452. [Full Text] [PDF]

				J.-C. Mamputu, N. Wiernsperger, and G. Renier Metformin inhibits monocyte adhesion to endothelial cells and foam cell formation The British Journal of Diabetes & Vascular Disease, July 1, 2003; 3(4): 302 - 310. [Abstract] [PDF]

				S. K. Jain, K. Kannan, G. Lim, J. Matthews-Greer, R. McVie, and J. A. Bocchini Jr Elevated Blood Interleukin-6 Levels in Hyperketonemic Type 1 Diabetic Patients and Secretion by Acetoacetate-Treated Cultured U937 Monocytes Diabetes Care, July 1, 2003; 26(7): 2139 - 2143. [Abstract] [Full Text] [PDF]

				L. Li, T. Sawamura, and G. Renier Glucose Enhances Endothelial LOX-1 Expression: Role for LOX-1 in Glucose-Induced Human Monocyte Adhesion to Endothelium Diabetes, July 1, 2003; 52(7): 1843 - 1850. [Abstract] [Full Text] [PDF]

				C. Kluft and J. Jespersen Review: Diabetes as a procoagulant condition The British Journal of Diabetes & Vascular Disease, September 1, 2002; 2(5): 358 - 362. [Abstract] [PDF]

				S. K. Jain, K. Kannan, G. Lim, R. McVie, and J. A. Bocchini Jr. Hyperketonemia Increases Tumor Necrosis Factor-{alpha} Secretion in Cultured U937 Monocytes and Type 1 Diabetic Patients and Is Apparently Mediated by Oxidative Stress and cAMP Deficiency Diabetes, July 1, 2002; 51(7): 2287 - 2293. [Abstract] [Full Text] [PDF]

				M. Soop, H. Duxbury, A. O Agwunobi, J. M. Gibson, S. J. Hopkins, C. Childs, R. G. Cooper, P. Maycock, R. A. Little, and G. L. Carlson Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1276 - E1285. [Abstract] [Full Text] [PDF]

				M. Ozata, D. Gungor, M. Turan, G. Ozisik, N. Bingol, T. Ozgurtas, and I. C. Ozdemir Improved Glycemic Control Increases Fasting Plasma Acylation-Stimulating Protein and Decreases Leptin Concentrations in Type II Diabetic Subjects J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3659 - 3664. [Abstract] [Full Text] [PDF]

				L. Ryysy and H. Yki-Järvinen Improvement of Glycemic Control by 1 Year of Insulin Therapy Leads to a Sustained Decrease in sE-Selectin Concentrations in Type 2 Diabetes Diabetes Care, March 1, 2001; 24(3): 549 - 554. [Abstract] [Full Text]

				S. Devaraj and I. Jialal Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients With and Without Macrovascular Complications : The Effect of {alpha}-Tocopherol Supplementation Circulation, July 11, 2000; 102(2): 191 - 196. [Abstract] [Full Text] [PDF]

				M. Guha, W. Bai, J. L. Nadler, and R. Natarajan Molecular Mechanisms of Tumor Necrosis Factor alpha Gene Expression in Monocytic Cells via Hyperglycemia-induced Oxidant Stress-dependent and -independent Pathways J. Biol. Chem., June 2, 2000; 275(23): 17728 - 17739. [Abstract] [Full Text] [PDF]

				T. Elhadd, T. Abdu, R. Clayton, and J. Belch Comment on Alteration of monocyte function in patients with growth hormone deficiency: Effect of substitutive GH therapy J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3405a - 3406. [Full Text]